Afficher la notice abrégée

Acceptability and feasibility of home and hospital follow-up in Burkina Faso and Guinea: A mixed-method study among patients of the COVID-19 Coverage-Africa clinical trial

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorPLAZY, Melanie
dc.contributor.authorDOUCET, Marie-Hélène
dc.contributor.authorTIMBO SONGBONO, Christine
dc.contributor.authorSANON, Anselme
dc.contributor.authorISSIAKA, Bamba
dc.contributor.authorMARTIN, Caroline
dc.contributor.authorDA, Inès
dc.contributor.authorL'HOSTELLIER, Anthony
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorMARCY, Olivier
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorMALVY, Denis
dc.contributor.authorPODA, Armel
dc.contributor.authorDELAMOU, Alexandre
dc.contributor.authorBERTHÉ, Abdramane
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorORNE-GLIEMANN, Joanna
dc.date.accessioned2023-10-17T09:53:26Z
dc.date.available2023-10-17T09:53:26Z
dc.date.issued2023-07-12
dc.identifier.issn2767-3375en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/184458
dc.description.abstractEnPatient experiences and perspectives on trial participation and follow-up may influence their compliance with research procedures or negatively impact their well-being. We aimed to explore the acceptability and feasibility of home-based and hospital-based follow-up modalities among COVID-19 patients enrolled in the ANTICOV ANRS COV33 Coverage-Africa trial in Burkina Faso and Guinea. The trial (2021-2022) evaluated the efficacy of treatments to prevent clinical worsening among COVID-19 patients with mild to moderate symptoms. Patients were either based at home or hospitalized, as per national recommendations, and followed-up through face-to-face visits and phone calls. We conducted a mixed-methods sub-study administering a questionnaire to all consenting participants and individually interviewing purposively selected participants. We performed descriptive analyses of Likert scale questions for the questionnaires and thematic analysis for the interviews. We conducted framework analysis and interpretation. Of the 400 trial patients, 220 completed the questionnaire (n = 182 in Burkina Faso, n = 38 in Guinea) and 24 were interviewed (n = 16 and n = 8, respectively). Participants were mostly followed-up at home in Burkina Faso; all patients from Guinea were first hospitalized, then followed-up at home. Over 90% of participants were satisfied with follow-up. Home follow-up was considered acceptable if (i) participants perceived they were not severely ill, (ii) it was combined with telemedicine, and (iii) the risk of stigma could be avoided. Hospital-based follow-up was viewed as a way to prevent contamination of family members, but could be badly experienced when mandatory and conflicting with family responsibilities and commitments. Phone calls were seen as reassuring and as a way to ensure continuity of care. These overall positive findings support the development of home-based follow-up for mildly ill patients in West-Africa, provided that both emotional and cognitive factors at individual, familial/inter-relational, healthcare and national levels be addressed when planning the implementation of a trial, or developing any public health strategy.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title.enAcceptability and feasibility of home and hospital follow-up in Burkina Faso and Guinea: A mixed-method study among patients of the COVID-19 Coverage-Africa clinical trial
dc.title.alternativePLOS Glob Public Healthen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1371/journal.pgph.0001545en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed37437024en_US
bordeaux.journalPLOS Global Public Healthen_US
bordeaux.pagee0001545en_US
bordeaux.volume3en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue7en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHIGSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAgence Nationale de Recherches sur le Sida et les Hépatites Viralesen_US
bordeaux.identifier.funderIDInstitut de Recherche pour le Développementen_US
bordeaux.identifier.funderIDEuropean and Developing Countries Clinical Trials Partnershipen_US
bordeaux.identifier.funderIDStarr Foundationen_US
bordeaux.identifier.funderIDStavros Niarchos Foundationen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04245828
hal.version1
hal.date.transferred2023-10-17T09:53:29Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLOS%20Global%20Public%20Health&rft.date=2023-07-12&rft.volume=3&rft.issue=7&rft.spage=e0001545&rft.epage=e0001545&rft.eissn=2767-3375&rft.issn=2767-3375&rft.au=PLAZY,%20Melanie&DOUCET,%20Marie-H%C3%A9l%C3%A8ne&TIMBO%20SONGBONO,%20Christine&SANON,%20Anselme&ISSIAKA,%20Bamba&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_PLOSGlobPublicHealth_2023_ ...
Taille:
958.2Ko
Format:
PDF
Voir/Ouvrir
Thumbnail
Nom:
license_rdf
Taille:
914octets
Format:
application/rdf+xml
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée